Pacira BioSciences (PCRX) Asset Utilization Ratio (2011 - 2026)

Pacira BioSciences' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.59 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 32.75% year-over-year to 0.59 in Q1 2026; TTM through Mar 2026 was 0.59, a 32.75% increase from a year earlier, with the FY2025 full-year figure at 0.52, up 15.01% from the prior year.
• Asset Utilization Ratio rose to 0.59 in Q1 2026 per PCRX's latest filing, from 0.57 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.59 in Q1 2026 and bottomed at 0.0 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.43 (2024), against an average of 0.34.
• Across the five-year window, Asset Utilization Ratio tumbled 99.73% in 2023 and jumped 43749.98% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 27643.02% to 0.43 in 2023, then climbed by 4.99% to 0.46 in 2024, then gained by 24.36% to 0.57 in 2025, then rose by 4.81% to 0.59 in 2026.
• Per Business Quant, the three latest PCRX Asset Utilization Ratio figures stand at 0.59 (Q1 2026), 0.57 (Q4 2025), and 0.51 (Q3 2025).